Hiro I.

Hiro I. has a diverse work experience starting with their current role as a Senior Research Associate II at Maze Therapeutics, where they began in January 2022. Prior to this, they were a Senior Research Associate I at Ambys Medicines from December 2019 to January 2022. Hiro also worked at Theravance Biopharma US, Inc., where they held the positions of Research Associate II from August 2018 to December 2019, and Research Associate I from July 2017 to August 2018. Before joining Theravance, Hiro worked as an Intern/Scientific Researcher at Genentech from October 2015 to July 2017. Their early professional experience includes serving as an Undergraduate Researcher at UC Berkeley from January 2013 to May 2015, where they also held the position of President from September 2011 to May 2015.

Hiro I. pursued higher education from 2011 to 2015 at the University of California, Berkeley. During this time, they earned a Bachelor of Science (B.S.) degree in Molecular Toxicology.